Archive - February 2025
Postpandemic Hospital Occupancy Up to 73.5 Percent, Sparking Concern
Saol Therapeutics Announces Submission of New Drug Application (NDA) to the U.S. FDA for SL1009
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
More Than Two-Thirds of U.S. Counties Do Not Have a Gastroenterologist
At 10 Years, Roux-en-Y Gastric Bypass Superior for Patient Excess BMI Loss
LIB Therapeutics Submits a Biologics License Application to FDA for Lerodalcibep for the Treatment of Adults with Elevated LDL-Cholesterol
Screen Time Tied to Manic Symptoms in Preteens
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia